Transgene Sa Stock Investor Sentiment

TRGNF Stock  USD 1.59  0.00  0.00%   
Roughly 56% of Transgene's investor base is looking to short. The analysis of overall sentiment of trading Transgene SA pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Transgene's historical and current headlines, can help investors time the market. In addition, many technical investors use Transgene SA stock news signals to limit their universe of possible portfolio assets.
Transgene pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Transgene daily returns and investor perception about the current price of Transgene SA as well as its diversification or hedging effects on your existing portfolios.
  
over two weeks ago at news.google.com         
Neurogenes stock sinks after adverse event with Rett syndrome gene therapy - Yahoo Finance
Google News at Macroaxis
over three weeks ago at news.google.com         
Transgene Reports Business, Pipeline and Financial Update for Q3 2024 - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Transgenes stock drops after Phase II cancer jab trial misses primary endpoint - Pharmaceutical Tech...
Google News at Macroaxis
over a month ago at news.google.com         
Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Met...
Google News at Macroaxis
over three months ago at news.google.com         
Even after rising 15 percent this past week, Transgene shareholders are still down 51 percent over t...
Google News at Macroaxis
over three months ago at news.google.com         
REGENXBIO Transforming Gene Therapy With Innovative AAV Treatments, Strong Buy - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
If You Had Bought Transgene Stock Five Years Ago, Youd Be Sitting On A 73 percent Loss, Today - Yaho...
Google News at Macroaxis
over six months ago at news.google.com         
Transgenes Combined General Meeting of May 15, 2024 - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Transgene provides business and financial update for Q1 2024 - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024 - Yahoo Finan...
Google News at Macroaxis
over six months ago at news.google.com         
Availability of Transgenes 2023 Universal Registration Document - GlobeNewswire
Google News at Macroaxis
over six months ago at news.google.com         
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head Neck...
Google News at Macroaxis
over six months ago at news.google.com         
Transgene Full Year 2023 Earnings Beats Expectations - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial...
Google News at Macroaxis
over six months ago at news.google.com         
Transgene Announces Upcoming Investor Meetings - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Transgene that are available to investors today. That information is available publicly through Transgene media outlets and privately through word of mouth or via Transgene internal channels. However, regardless of the origin, that massive amount of Transgene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Transgene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Transgene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Transgene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Transgene alpha.

Transgene Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Transgene Pink Sheet analysis

When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital